Pharmaceutical Benefits Advisory Committee (PBAC)
Pharmaceutical Benefits Advisory Committee (PBAC)
The PBAC is an independent expert body appointed by the Australian Government. Members include doctors, health professionals, health economists and consumer representatives.
Its primary role is to recommend new medicines for listing on the PBS. No new medicine can be listed unless the committee makes a positive recommendation. The PBAC meets three times a year, usually in March, July and November.
When recommending a medicine for listing, the PBAC takes into account the medical conditions for which the medicine was registered for use in Australia, its clinical effectiveness, safety and cost-effectiveness (‘value for money’) compared with other treatments.
PBAC has two sub-committees to assist with analysis and advice in these areas:
Contact details for the PBAC can be found in PBS Contacts
Agendas, outcomes and public summary documents of PBAC meetings can be found under elements of the listing process
Dr Suzanne Hill is a clinical pharmacologist previously employed as a Scientist in the Department of Medicines Policy and Standards at the World Health Organisation (WHO) in Geneva, Switzerland. Prior to this she was Associate Professor/ Senior Lecturer, Clinical Pharmacology, Faculty of Medicine and Health Sciences, University of Newcastle.
Dr John Bennett is a general practitioner and Practice Principal of the University Health Service at the University of Queensland. He is also a casual lecturer and tutor in Epidemiology, Public Health, Evidence Based Medicine, Medical Informatics and Primary Care Medical School at University Of Queensland.
Dr Jim Buttery is Research Development Director, NHMRC Centre for Clinical Research Excellence in Child and Adolescent Immunisation and a consultant paediatrician and Infectious disease physician and the Royal Children’s Hospital, Victoria.
Professor Terry Campbell is Professor of Medicine at University of New South Wales and Head of the Department of Medicine, St Vincent's Hospital, Sydney.
Professor Catherine Cole is a consultant paediatric haematologist and oncologist at Princess Margaret Hospital for Children, Perth WA and Director Laboratory Haematology, PathCentre, QEII Medical Centre Perth WA. She is also Director of Paediatric and Adolescent Haematology/Oncology at the University of WA.
Dr Marion Davies is a rural generalist (GP) registrar for WA Health and has considerable experience in the provision of medical treatment to rural and aboriginal communities as well as a background in clinical and community pharmacy.
Professor Christopher Etherton-Beer is a clinical academic in Geriatric Medicine at the University of Western Australia and is a Geriatrician/ Clinical Pharmacologist at Royal Perth Hospital. Professor Etherton-Beer has research interests in ageing and aged care, stroke, medical education and pharmaco-geriatrics.
Associate Professor Jenny Gunton is an endocrinologist working as a researcher at the Garvan Institute of Medical Research. She is also a staff specialist at Westmead Hospital and President of the Australian Diabetes Society.
Professor David Isaacs is Clinical Professor at the University of Sydney. He is a paediatrician at the Department of Infectious Diseases and Microbiology, based at The Children’s Hospital at Westmead in Sydney.
Professor Geoff McColl is a rheumatologist and Professor of Medical Education and Training in the Melbourne Medical School at the University of Melbourne.
Associate Professor David Newby is a community pharmacist at Bateau Bay in NSW, acting Discipline Lead in Clinical Pharmacology, Joint Medical Program, and the Course coordinator for Epidemiology and pharmacoeconomics, Master of Pharmacy Program in the Faculty of Health at the University of Newcastle.
Professor Andrew Roberts is a practising Clinical Haematologist and medical researcher. Professsor Roberts is an NHMRC Practitioner Fellow, Div of Cancer and Haematology at The Walter and Eliza Hall Institute of Medical Research.
Dr Rashmi Sharma is a general practitioner and Practice Principal of a large teaching practice in Canberra where she supervises nursing and medical students, interns and GP registrars. She is a Senior Lecturer at the ANU Medical School and President of the ACT Division of General Practice. She is a board member and medical educator for the regional general practice training provider, Coast City Country GP Training Ltd.
Associate Professor Rosalie Viney is a health economist at the Centre for Health Economics Research and Evaluation, University of Technology, Sydney. She is Chair of the PBAC Economics Sub-Committee.
Professor Robyn Ward is the Clinical Associate Dean at Prince of Wales Clinical School, UNSW, and Director of Cancer Services for South Eastern Sydney and Illawarra Local Health Networks. She is a practising medical oncologist and a medical researcher.
Ms Jo Watson is the Executive Director of the National Association of People With HIV Australia (NAPWHA) and is an experienced consumer advocate having over 10 years as a member of the Pharmaceutical Benefits Pricing Authority (PBPA).
Dr Frances Wilson is Senior Staff Specialist in Psychiatry and Clinical Director, Adult Psychiatry Unit at Westmead Hospital. She is a Clinical Senior Lecturer at Sydney University.